Ares Financial Consulting’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.5K Buy
825
+45
+6% +$3.63K 0.05% 188
2026
Q1
$67.1K Hold
780
0.05% 172
2025
Q4
$74.9K Buy
+780
New +$75.8K 0.07% 126

Other funds holding MDT

Ares Financial Consulting's MDT Position: Q2 2026 in Review

Ares Financial Consulting increased its Medtronic (MDT) stake by 5.8% in Q2 2026, buying an estimated $3.63K and bringing the position to 825 shares worth $64.5K. The position accounts for 0.05% of the portfolio, ranked #188.

Ares Financial Consulting first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $74.9K in Q4 2025. 1,162 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ares Financial Consulting held 825 shares of Medtronic worth $64.5K as of Q2 2026.
  • Ares Financial Consulting bought 45 Medtronic shares in Q2 2026, an estimated $3.63K.
  • Medtronic made up 0.05% of Ares Financial Consulting's portfolio in Q2 2026, its #188 holding.
  • Ares Financial Consulting first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Ares Financial Consulting's Medtronic position peaked at $74.9K in Q4 2025.
  • 1,162 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.